SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-767892
Filing Date
2016-11-14
Accepted
2016-11-14 17:23:32
Documents
50
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d264249d10q.htm 10-Q 337564
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER d264249dex311.htm EX-31.1 5989
3 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER d264249dex312.htm EX-31.2 5972
4 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 d264249dex321.htm EX-32.1 2631
5 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 d264249dex322.htm EX-32.2 2614
  Complete submission text file 0001193125-16-767892.txt   2682263

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ogen-20160930.xml EX-101.INS 360598
7 XBRL TAXONOMY EXTENSION SCHEMA ogen-20160930.xsd EX-101.SCH 39757
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ogen-20160930_cal.xml EX-101.CAL 45641
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ogen-20160930_def.xml EX-101.DEF 135176
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ogen-20160930_lab.xml EX-101.LAB 332833
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ogen-20160930_pre.xml EX-101.PRE 229284
Mailing Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634
Business Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634 8132867900
ORAGENICS INC (Filer) CIK: 0001174940 (see all company filings)

IRS No.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32188 | Film No.: 161995989
SIC: 2834 Pharmaceutical Preparations